Clinical Presentation of Granuloma Inguinale (Donovanosis)

Granuloma inguinale (also known as donovanosis) is a sexually-transmitted clinical entity that presents with readily bleeding genital ulcerations. This condition is encountered in diverse regions of the world, most of which have scanty medical research capabilities.

The causative microorganism is generally reported as Calymmatobacterium granulomatis, which is a Gram-negative, encapsulated pleomorphic bacterial pathogen. However, due to close phylogenetic resemblance with certain representatives of the genus Klebsiella, in recent years the organism was reclassified as Klebsiella granulomatis comb. nov.

A Variety of Clinical Forms

After an average incubation period of 17 days, this condition starts to become clinically apparent. Although the initial sign of infection is usually a firm papule or a nodule under skin that has the propensity to ulcerate, there are four principal types of granuloma inguinale:

  • Ulcerograulomatous type – the most common type of disease that is characterized by single or multiple fleshy, non-tender, exuberant ulcers which may bleed upon touching
  • Verrucous (or hypertrophic) type – in this type the ulcer is characterized raised, irregular edges, often presenting with a dry, walnut-like appearance
  • Necrotic type – the ulcer is deep and foul-smelling with concomitant tissue destruction
  • Sclerotic (or cicatricial) type – substantial formation of fibrous and scar tissue is seen in this type, but histopathological examination is warranted for disease confirmation

The main predilection spot are genitals which are involved in 90% of all cases, while the inguinal region is affected in 10% of cases. In women, the labia minora and the posterior margin of the vulva are most often affected; in men, usual sites of infection are prepuce, frenulum, coronal sulcus and glans penis (hence uncircumcised men are at greater risk of acquiring this condition).

Extragenital lesions are observed in 6% of cases and may present on the lips, cheeks, nose, neck, throat and chest. They are usually linked to primary genital disease, thus in primary extragenital lesions one should always consider a possibility of rhinoscleroma (a chronic, granulomatous infection of the nose caused by a similar pathogen).

Donovanosis does not involve lymph nodes, which is a feature that discriminates this condition from chancroid and lymphogranuloma venereum. Disseminated form of the disease is quite rare, albeit secondary spread to bone and liver may occur (usually in association with pregnancy).

Donovanosis, otherwise known as granuloma inguinale
A very large erosive cutaneous lesion in the perineal region of this patient, which had been diagnosed as Donovanosis, otherwise known as granuloma inguinale, a genital ulcerative disease caused by the Gram-negative bacterium, Klebsiella granulomatis, formerly known as Calymmatobacterium granulomatis, and even earlier Donovania granulomatis. The causative organism is difficult to culture, and diagnosis requires visualization of dark-staining Donovan bodies on tissue crush preparation from a biopsy. Image Credit: CDC/ Joe Miller

Complications and Consequences

The most frequent complication in modern era is pseudoelephantiasis (in up to 5% of all the affected individuals), which is more commonly observed in women. In the cicatricial type of donovanosis there is a possibility of urethral, vaginal or anal stenosis.

Luckily, carcinomas are rarely reported nowadays, but they are still a dreaded complication of this condition. One study found cancer as a sequel of donovanosis in only 0.25% of positive cases, while a study from Jamaica found that Klebsiella granulomatis comb. nov. antigens were reactive in 14.5% of penile carcinoma.

Ulcers in granuloma inguinale can be co-infected with other sexually-transmitted diseases – most notably syphilis. Such cases should be managed by employing a ‘syndromic approach’ (i.e. clinical decision-making based on symptoms and signs, and not primarily on precise diagnosis).

Also, donovanosis increases the risk of HIV infection, which results in protracted lesion presence. Furthermore, HIV-positive individuals experience increased tissue damage and require more time for scars to develop. There is also a report of co-existent squamous cell carcinoma in HIV-positive patient.


Further Reading

Last Updated: Jan 25, 2019

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2019, January 25). Clinical Presentation of Granuloma Inguinale (Donovanosis). News-Medical. Retrieved on July 25, 2024 from

  • MLA

    Meštrović, Tomislav. "Clinical Presentation of Granuloma Inguinale (Donovanosis)". News-Medical. 25 July 2024. <>.

  • Chicago

    Meštrović, Tomislav. "Clinical Presentation of Granuloma Inguinale (Donovanosis)". News-Medical. (accessed July 25, 2024).

  • Harvard

    Meštrović, Tomislav. 2019. Clinical Presentation of Granuloma Inguinale (Donovanosis). News-Medical, viewed 25 July 2024,


  1. Aryan Anderson Aryan Anderson Australia says:

    Hi Dr Tomislav
    What would be the Immune response to Donovanosis and how the body immune system would react to Donovan bodies?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.